Gyre TherapeuticsGYRE
13F holders, Q2 2025 (June 30)48holders +3
9new positions
7sold out
$7.35avg. 13F price*
At the end of Q2 2025, 48 institutions reported holding Gyre Therapeutics Inc. (GYRE) in their 13F filings, up 3 from Q1 2025. 9 opened new positions and 7 sold out. The largest holders were Vanguard Group Inc. ($8.5M), BlackRock, Inc. ($6.2M) and Geode Capital Management, LLC ($3.0M).
- Company
- Gyre Therapeutics Inc.
- CUSIP
- 403783103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $835K |
| Exits | 7 | $266K |
All 13F filers, Q1 2025 → Q2 2025: 863,384 shares bought and 62,972 shares sold, net +800,412 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Vanguard Group Inc. | 0.00% | Add +4.8% | 1,149,709 | $8.5M |
| BlackRock, Inc. | 0.00% | Add +54.0% | 842,609 | $6.2M |
| Geode Capital Management, LLC | 0.00% | Add +28.6% | 401,709 | $3.0M |
| SBI Securities Co., Ltd. | 0.05% | Add +87.9% | 232,299 | $1.7M |
| State Street Corp. | 0.00% | Add +38.0% | 177,768 | $1.3M |
| Northern Trust Corp. | 0.00% | Add +32.7% | 143,329 | $1.1M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +16.2% | 129,420 | $951K |
| State of Wisconsin Investment Board | 0.00% | New | 37,670 | $277K |
| Susquehanna International Group, LLP | 0.00% | Add +112.1% | 35,912 | $264K |
| Morgan Stanley | 0.00% | Add +151.3% | 35,258 | $259K |
| Barclays PLC | 0.00% | Add +184.0% | 24,004 | $176K |
| Bank of New York Mellon Corp | 0.00% | Add +45.5% | 23,989 | $176K |
| Alliancebernstein L.P. | 0.00% | New | 19,930 | $146K |
| Nuveen, LLC | 0.00% | New | 17,594 | $129K |
| Rhumbline Advisers | 0.00% | Add +45.3% | 16,186 | $119K |
| Verition Fund Management LLC | 0.00% | New | 13,345 | $98K |
| STRS Ohio | 0.00% | New | 13,300 | $98K |
| American Century Companies Inc. | 0.00% | Reduce -52.6% | 11,291 | $83K |
| Deutsche Bank AG | 0.00% | New | 10,927 | $80K |
| FMR LLC | 0.00% | Add +2796.8% | 10,892 | $80K |
| UBS Group AG | 0.00% | Reduce -64.5% | 8,639 | $63K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +77.8% | 7,413 | $54K |
| Wells Fargo & Company | 0.00% | Add +70.8% | 7,015 | $52K |
| JPMorgan Chase & Co. | 0.00% | Add +84.6% | 6,461 | $47K |
| Bank of America Corp. | 0.00% | Add +28.8% | 6,277 | $46K |
| Royal Bank of Canada | 0.00% | Add +1497.5% | 6,262 | $45K |
| Citigroup Inc. | 0.00% | Add +22.3% | 5,937 | $44K |
| New York State Common Retirement Fund | 0.00% | No change | 2,700 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +102.5% | 2,124 | $16K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | No change | 2,097 | $15K |
| Legal & General Group Plc | 0.00% | Add +150.9% | 1,513 | $11K |
| Aster Capital Management (DIFC) Ltd | 0.00% | Add +2352.5% | 1,447 | $11K |
| BNP Paribas Financial Markets | 0.00% | Add +161.8% | 1,296 | $10K |
| California State Teachers Retirement System | 0.00% | Add +67.7% | 847 | $6K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 683 | $5K |
| Raymond James Financial Inc. | 0.00% | New | 650 | $5K |
| Activest Wealth Management | 0.00% | No change | 533 | $4K |
| Amalgamated Bank | 0.00% | No change | 241 | $2K |
| Cwm, LLC | 0.00% | Reduce -10.2% | 123 | $1K |
| GAMMA Investing LLC | 0.00% | Reduce -47.5% | 124 | $911 |
| Principal Securities, Inc. | 0.00% | New | 85 | $625 |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -3.3% | 59 | $434 |
| Rise Advisors, LLC | 0.00% | New | 54 | $397 |
| Osaic Holdings, Inc. | 0.00% | Add +245.4% | 38 | $279 |
| Sterling Capital Management LLC | 0.00% | Reduce -68.9% | 33 | $243 |
| Essential Partners LLC | 0.00% | — | 2 | $15 |
| IFP Advisors, Inc | 0.00% | Reduce -50.0% | 1 | $7 |
| Covestor Ltd | 0.00% | Reduce -14.3% | 6 | $0 |
"% of holder's portfolio" is GYRE's weight in each manager's 13F, not the share of Gyre Therapeutics Inc. the manager owns.